telaprevir Articles
Vertex maintains 2010 outlook, reveals launch plan for hep C drug telaprevir and progress of other programs
11 January 2011
Liver disease meeting hears updates on Merck & Co’s boceprevir, Boehringer Ingelheim’s HCV combo, Vertex’ telaprevir and Gilead’s Viread
2 November 2010
75% of treatment-naive chronic hepatitis C patients achieve SVR with Vertex’ telaprevir in Ph III trial
27 May 2010
Showing 1-7 of 7 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
